Long-term efficacy and safety of repeated botulinum toxin a applications based on function and anesthesia type in

Murat Celal Sozbilen1, Kubra Evren Sahin2

  • 1Department of Orthopaedic Surgery, School of Medicine Hospital, Ege University, Bornova, Izmir, Turkey.

Journal of Orthopaedics
|January 14, 2022
PubMed

Insights

Repeated Botulinum toxin A (BoNT-A) injections improve motor skills in children. Sedation analgesia offers faster recovery for initial treatments, but recovery time lengthens with more applications.

Area of Science:

  • Pediatric Neurology
  • Rehabilitation Medicine
  • Anesthesiology

Background:

  • Botulinum toxin A (BoNT-A) injections are used to manage spasticity in pediatric patients.
  • Repeated applications are often necessary for sustained therapeutic effects.
  • Anesthesia choice impacts patient recovery and procedural efficiency.

Purpose of the Study:

  • To assess motor development following repeated Botulinum toxin A (BoNT-A) applications in pediatric patients.
  • To compare the safety and efficacy of three anesthesia methods (sedation analgesia, laryngeal mask anesthesia, inhalation mask) in these procedures.

Main Methods:

  • Evaluation of 75 children with at least three consecutive BoNT-A applications (320 procedures total).
  • Motor development assessed using the Gross Motor Function Classification System (GMFCS).
  • Comparison of anesthesia types based on sedation, procedure, recovery, and operating room time.

Main Results:

  • Significant motor development observed in 80% of patients post-BoNT-A treatment.
  • Shorter recovery times noted with sedation analgesia during the first three procedures.
  • No significant difference in recovery time among anesthesia methods after the fourth procedure.
  • Recovery time increased with six or more procedures, irrespective of anesthesia type.

Conclusions:

  • Repeated BoNT-A applications are safe and effective for improving motor function in children.
  • Sedation analgesia facilitates quicker recovery for the initial treatments.
  • Increased number of BoNT-A applications correlates with longer recovery times, highlighting the need for careful anesthetic management.
Abstract

Related Concept Videos

Skeletal Muscle Relaxants: Therapeutic Uses01:31

Skeletal Muscle Relaxants: Therapeutic Uses

Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
681
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin01:26

Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin

Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
820
Local Anesthetics: Clinical Application as Spinal Anesthesia01:11

Local Anesthetics: Clinical Application as Spinal Anesthesia

Spinal anesthetics are given during lower abdomen and limb surgeries to block sensory and motor neurons. They are administered in the mid to low lumbar regions, primarily acting on the cauda equina's nerve roots. The blockade level depends on the local anesthetic (LA) concentration. Usually, low LA concentrations are sufficient to block sensory fibers, while only high LA concentrations block motor fibers. Other factors like injection volume and speed, the patient's posture, and the drug...
870
Depolarizing Blockers: Pharmocokinetics01:19

Depolarizing Blockers: Pharmocokinetics

Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
402
Long-term Potentiation01:35

Long-term Potentiation

Long-term potentiation, or LTP, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTP is the process of synaptic strengthening that occurs over time between pre- and postsynaptic neuronal connections. The synaptic strengthening of LTP works in opposition to the synaptic weakening of long-term depression (LTD) and together are the main mechanisms that underlie learning and memory.
56.1K
Peripherally and Centrally Acting Muscle Relaxants: A Comparison01:09

Peripherally and Centrally Acting Muscle Relaxants: A Comparison

Skeletal muscle relaxants can target the central nervous system [CNS] to reduce muscle tension or act directly at the neuromuscular junction to induce temporary paralysis. These two classes of muscle relaxants are called centrally acting muscle relaxants and peripherally acting muscle relaxants. They differ in their action, mechanism, administration route, and clinical uses.
Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic...
3.8K